Tissue rigidity promotes tumor progressionSeptember 20, 2005Most investigations into cancer have focused on chemical signals, but a new research study provides rare insight into how mechanical force can regulate cellular behavior. The study uncovers a link between tissue tension and tumor formation, suggesting that the stiffness of a tissue can influence molecular signals that promote the malignant behavior of tumor cells. The findings, published in the September issue of Cancer Cell, provide exciting new insight into the mechanisms that link the tissue microenvironment with tumorigenesis, and may identify new targets for tumor therapies. Tumors are more rigid than normal tissues, and palpation of compliant tissues to look for a rigid tissue mass has been used as a method of cancer detection for some time. However, the relationship between tissue stiffness and the behavior of tumor cells is not well understood. Dr. Valerie M. Weaver, from the University of Pennsylvania in Philadelphia, and colleagues examined cancer cells developing within a three-dimensional gel system in which rigidity could be carefully controlled to look at how tissue stiffening might drive malignant behavior of cancer cells.
Research focused on a class of molecules called integrins that function as transducers of physical cues and are known to regulate growth factor signaling. The researchers found that even a slight increase in the stiffness of the surrounding matrix perturbed tissue architecture and enhanced growth by inducing Rho-generated cytoskeletal tension to promote assembly of integrin-associated attachments called focal adhesions and increase growth factor-dependent ERK activation. Further, a decrease in Rho or ERK activity in cancerous cells was associated with a subsequent decline of focal adhesions and a reversion of aberrant morphological structures. The results of the research study provide a link between exogenous force, Rho-associated cytoskeletal tension, focal adhesions, and growth factor activation of ERK, and offer a fresh perspective for understanding the molecular basis of tissue differentiation and tumor formation. According to Dr. Weaver, "ERK and Rho appear to be part of an integrated mechanoregulatory circuit that functions to link physical cues through integrins to molecular pathways that control cell growth. A chronic increase in cytoskeletal tension could enhance growth and perturb tissue organization, thereby promoting malignant transformation of a tissue." Cell Press | |||||||||||||||||||||
|
Related Tumor Progression Current Events and Tumor Progression News Articles A potential targets for the prevention or treatment of esophageal carcinoma Expression of Livin in fresh esophageal cancer tissues was detected by immunohistochemistry (IHC), Western blotting and reverse transcriptase-polymerase chain reaction (RT-PCR), VEGF by Its correlation Western blotting and RT-PCR. Researchers identify mechanism used by gene to promote metastasis in human cancer cells Virginia Commonwealth University Institute of Molecular Medicine and VCU Massey Cancer Center researchers have discovered how a gene, melanoma differentiation associated gene-9/syntenin (mda-9/syntenin), interacts with an important signaling protein to promote metastasis in human melanoma cells, a discovery that could one day lead to the development of the next generation of anti-metastatic drugs for melanoma and other cancers. New approach to gene therapy may shrink brain tumors, prevent their spread Massachusetts General Hospital (MGH) researchers are investigating a new approach to gene therapy for brain tumors - delivering a cancer-fighting gene to normal brain tissue around the tumor to keep it from spreading. CSHL scientists identify new drug target against virulent type of breast cancer Tumor cells in a particular subset of breast cancer patients churn out too much of a protein called ErbB2 -- also often called HER2 -- which drives the cells to proliferate unchecked. Patients unlucky enough to be in this group -- about one in four -- have poorer prognoses and clinical outcomes than those who don't. Rheb's role in cancer Two independent papers in the August 15th issue of G&D identify the Rheb GTPase as a novel oncogene and a promising new chemotherapeutic target. Targeted radiation therapy can control limited cancer spread Precisely targeted radiation therapy can eradicate all evidence of disease in selected patients with cancer that has spread to only a few sites, suggests the first published report from an ongoing clinical trial. Experimental agent blocks prostate cancer in animal study An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows. MR imaging accurately determines prostate cancer treatment failure Dynamic contrast-enhanced MRI (DCE-MRI) plus diffusion weighted imaging (DWI) can accurately diagnose residual or recurrent prostate cancer in patients treated with high-intensity focused ultrasonic ablation, a new study shows. Researchers identify new cell targets for preventing growth of breast and other tumors Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression. Researchers identify new cell targets for preventing growth of breast and other tumors Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression. More Tumor Progression Current Events and Tumor Progression News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||